Abstract
The study of protein-drug interaction is of pivotal importance to understand the structural features essential for ligand affinity. The explosion of information about protein structures has paved the way to develop structure-based virtual screening approaches. Parasitic protein kinases have been pointed out as potential targets for antiparasitic development. The identification of protein kinases in the Plasmodium falciparum genome has opened the possibility to test new families of inhibitors as potential antimalarial drugs. In addition, other key enzymes which play roles in biosynthetic pathways, such as enoyl reductase and chorismate synthase, can be valuable targets for drug development. This review is focused on these protein targets that may help to materialize new generations of antimalarial drugs.
Keywords: Plasmodium falciparum, antimalarial drugs, structure-based virtual screening, protein kinases, enoyl reductase, chorismate synthase
Current Drug Targets
Title: Protein-Drug Interaction Studies for Development of Drugs Against Plasmodium falciparum
Volume: 10 Issue: 3
Author(s): Walter Filgueira de Azevedo Jr., Rafael Andrade Caceres, Ivani Pauli, Luis Fernando S.M. Timmers, Guy Barros Barcellos, Kelen Beiestorf Rocha and Milena Botelho Pereira Soares
Affiliation:
Keywords: Plasmodium falciparum, antimalarial drugs, structure-based virtual screening, protein kinases, enoyl reductase, chorismate synthase
Abstract: The study of protein-drug interaction is of pivotal importance to understand the structural features essential for ligand affinity. The explosion of information about protein structures has paved the way to develop structure-based virtual screening approaches. Parasitic protein kinases have been pointed out as potential targets for antiparasitic development. The identification of protein kinases in the Plasmodium falciparum genome has opened the possibility to test new families of inhibitors as potential antimalarial drugs. In addition, other key enzymes which play roles in biosynthetic pathways, such as enoyl reductase and chorismate synthase, can be valuable targets for drug development. This review is focused on these protein targets that may help to materialize new generations of antimalarial drugs.
Export Options
About this article
Cite this article as:
de Azevedo Jr. Filgueira Walter, Caceres Andrade Rafael, Pauli Ivani, Timmers S.M. Luis Fernando, Barcellos Barros Guy, Rocha Beiestorf Kelen and Soares Botelho Pereira Milena, Protein-Drug Interaction Studies for Development of Drugs Against Plasmodium falciparum, Current Drug Targets 2009; 10 (3) . https://dx.doi.org/10.2174/138945009787581104
DOI https://dx.doi.org/10.2174/138945009787581104 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Compendious Review on Bioactive Constituents and Pharmacotherapeutic
Profile of Heliotropium indicum Linn
The Natural Products Journal Editorial [Hot Topic:Protein targets for development of drugs against Mycobacterium tuberculosis (Guest Editor: Walter Filgueira de Azevedo)]
Current Medicinal Chemistry Structure- and Ligand-Based Structure-Activity Relationships for a Series of Inhibitors of Aldolase
Current Computer-Aided Drug Design New Pyrroles with Potential Antimycobacterial, Antifungal and Selective COX-2 Inhibiting Activities. Synthetic Methodologies
Current Organic Chemistry Current Study of the Detection and Treatment Targets of Spinal Tuberculosis
Current Drug Targets Advancement in Nanoparticle-based Biosensors for Point-of-care <i>In vitro</i> Diagnostics
Current Topics in Medicinal Chemistry Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design
Current Drug Targets Current Study of Natural Products for Medicinal Chemistry
Current Medicinal Chemistry Chemical Constituents and Biological Activities of Cordia myxa L.: A Review
The Natural Products Journal Studies and Syntheses of Siderophores, Microbial Iron Chelators, and Analogs as Potential Drug Delivery Agents
Current Medicinal Chemistry NMDA Pathology and Treatment of Schizophrenia
Current Pharmaceutical Design Xanthone: A Promising Antimycobacterial Scaffold
Medicinal Chemistry From Mice to Macaques – Animal Models of HIV Nervous System Disease
Current HIV Research Potential Therapeutic Agents from the Red Sea Organisms
Medicinal Chemistry From Nucleic Acids to Drug Discovery: Nucleobases as Emerging Templates for Drug Candidates
Current Medicinal Chemistry Relevance of Anxiety and Depression in Chronic Obstructive Pulmonary Disease (COPD)
Current Respiratory Medicine Reviews Women’s Health in Central America: The Complexity of Issues and the Need to Focus on Indigenous Healthcare
Current Women`s Health Reviews Advances in Biologic Agents for the Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Exploiting HPV-Induced Carcinogenesis for a Rational Drug Development in Cervical Cancer
Current Cancer Drug Targets The Relative Transcription Index: A Gene Expression Based Metric for Prioritization of Drug Candidates
Combinatorial Chemistry & High Throughput Screening